option delistings on September 25th
PremiumThe Flyoption delistings on September 25th
1y ago
ContraFect announces submission of IND application to FDA for CF-370
Premium
The Fly
ContraFect announces submission of IND application to FDA for CF-370
1y ago
ContraFect reports Q2 EPS ($1.94) vs ($36.79) last year
Premium
The Fly
ContraFect reports Q2 EPS ($1.94) vs ($36.79) last year
1y ago
ContraFect announces first patient dosed in Phase 1b/2 study of exebacase
PremiumThe FlyContraFect announces first patient dosed in Phase 1b/2 study of exebacase
2y ago
ContraFect presents CF-370 data at annual EECMID meeting
Premium
The Fly
ContraFect presents CF-370 data at annual EECMID meeting
2y ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
2y ago
ContraFect announces pricing of $7M registered directoffering
PremiumThe FlyContraFect announces pricing of $7M registered directoffering
2y ago
ContraFect announces ANSM approval of CTA for exebacase
Premium
The Fly
ContraFect announces ANSM approval of CTA for exebacase
2y ago
2 “Strong Buy” Penny Stocks With Massive Upside Potential
Premium
Stock Analysis & Ideas
2 “Strong Buy” Penny Stocks With Massive Upside Potential
3y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100